Study of ARO-RAGE in Healthy Subjects and Patients With Inflammatory Lung Disease

NCT05276570 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: ARO-RAGE
DRUG: Placebo

Sponsor

Arrowhead Pharmaceuticals